Calcitonin Salmon

Calcitonin Salmon

产品编号 :
Cas No. :
包装规格 纯度 目录价 会员专享价 库存 数量
5mg 95% 询价
- +
10mg 95% 询价
- +
25mg 95% 询价
- +
50mg 95% 询价
- +
晶智化学产品均仅供科研使用。在任何情况下,我们均不提供用于动物或人体用途的产品或服务。

基础信息

CAS No.

47931-85-1

英文名称

Calcitonin Salmon

别名

salmoncalcitonin-(i-32);salmoncalcitonini;tz-ct;Salmon Calcitonin Acetate;Salcatonin;CALCITONIN SALMON 250 UG;CalcitoninAcetate;Salmon Calcium

MDL No.

MFCD00133859

分子式

C145H240N44O48S2

分子量

3431.91

精确分子量

3429.71

SMILES

CC(C[C@@H](C(NCC(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N1CCC[C@H]1C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(NCC(N[C@H](C(NCC(N[C@H](C(N2CCC[C@H]2C(N)=O)=O)[C@H](O)C)=O)=O)CO)=O)=O)[C@H](O)C)=O)CC(N)=O)=O)[C@H](O)C)=O)CCCNC(N)=N)=O)=O)CC3=CC=C(C=C3)O)=O)[C@H](O)C)=O)CCC(N)=O)=O)CC(C)C)=O)CCCCN)=O)CC4=CN=CN4)=O)CC(C)C)=O)CCC(O)=O)=O)CCC(N)=O)=O)CO)=O)CC(C)C)=O)CCCCN)=O)=O)NC([C@H](C(C)C)NC([C@@H]5CSSC[C@@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N5)=O)[C@H](O)C)=O)CO)=O)CC(C)C)=O)CC(N)=O)=O)CO)=O)N)=O)=O)C

标准SMILES

CC(C)[C@H](NC(=O)[C@@H]1CSSC[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CN=CN1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N1CCC[C@H]1C(N)=O

用途

Treatment of high-turnover bone diseases such as osteoporosis (particularly postmenopausal osteoporosis with more pronounced effects on axial bones than appendicular bones), Paget's disease of bone, Sudeck's atrophy (reflex sympathetic dystrophy), and malignant osteolysis; inhibition of osteoclast activity and stimulation of osteoblast formation and activity; reduction of bone resorption and calcium loss; management of hypercalcemia (immediate treatment); analgesic effects in certain painful bone disorders through inhibition of pain mediator release, receptor blockade, and increased β-endorphin release; suppression of gastric and pancreatic secretions without affecting gastrointestinal motility.

InChIKey

BBBFJLBPOGFECG-VJVYQDLKSA-N

安全信息

SureRoute逆合成路线

1.  47931-85-1 逆合成路线 1

—
—
ACRKDF303
47931-85-1
来源: SureRoute

2.  47931-85-1 逆合成路线 2

—
—
ACRKDF303
47931-85-1
来源: SureRoute

3.  47931-85-1 逆合成路线 3

—
—
ACRKDF303
47931-85-1
来源: SureRoute
评论 0
我是晶智Agent,
您的化学小助手